Align Technology (ALGN) vs peers
ALGN's EV/Sales is 2.4x, compared with 5.8x at the middle of 2 peers.
Health Care Supplies. Updated .
| Stock | EV/Sales | Own 5-year rank |
|---|---|---|
| ALGNAlign Technology | 2.4x | 7% |
| WSTWest Pharmaceutical Services | 8.4x | 63% |
| COOCooper Companies (The) | 3.3x | 2% |
How to read this comparison
Up to eight covered companies in the same industry, largest market value first.
EV/Sales divides enterprise value (stock market value plus debt, less cash) by revenue from the previous twelve months. The middle peer reading excludes ALGN and unavailable values.
Own 5-year rank compares each stock with its available weekly readings within the last five years. At least 26 usable weeks are required. A rank of 20% means its current multiple is above 20% of its past readings. It is not a rank against the other stocks in this table.
Dates show data updates; the latest available weekly observation can differ between stocks. Different growth rates, margins and financial risks can explain different multiples. Missing or non-positive denominators are left unranked.